Clinical investigation of drug-eluting stent in treatment of elderly female patients with multi-vessel coronary artery disease

Yang Guitang,Han Yaling,Liu Haiwei
DOI: https://doi.org/10.3321/j.issn:0577-7402.2006.06.007
2006-01-01
Medical Journal of Chinese People's Liberation Army
Abstract:Objective To retrospectively analyze the effectiveness and safety of drug-eluting stents (DES) on prevention of restenosis in old female patients (≥65 years) with multi-vessel coronary artery disease. Methods 387 old female patients with multi-vessel coronary artery disease underwent percutaneous coronary intervention (PCI) were divided into the DES group (n=139) and the metallic stent (BMS) group (n=248). Acute and long-term outcomes were compared between the two groups. Results The ratio of patients with diabetic disease was higher in DES group than that in BMS group (P<0.05). The ratios of hypertension, seriousness of coronary lesion, heart function, success rates of therapeutic measures were not significantly different between the two groups. Mean follow-up duration for 371 patients was 20.8 ±12.6 months. Angiographic follow-up rate was similar in the two groups (53.7%in DES group vs 56.1% in BMS group, P>0.05). The rates of restenosis shown by angiography and major adverse cardiac events (MACE) were significantly lower in the DES group compared with BMS group (4.2% vs 15.8%, 7.5% vs 17.3%, P<0.05). Conclusion The implantation of DES inelderly female patients with multi-vessel disease can achieve high success rate, low rates of complications and restenosis and good long-term clinical outcome.
What problem does this paper attempt to address?